Trial intelligence / Profile preview

Pempuls Trial

NCT00127764Phase 3Completed

Sponsor
University Medical Center Groningen
Start
Jan 2001
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in pemphigus comparing Dexamethasone pulse therapy with Placebo pulse therapy (2 arms). Primary endpoints: Rate of complete remission with pulse therapy and Number of weeks in complete remission after 12 months. Started Jan 2001; status: completed.

02

Drugs

dexamethasone
03

Conditions

pemphigus

Beyond the preview

Go deeper on NCT00127764.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00127764.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call